Engineering functional microbial inoculants for cigar tobacco fermentation: metabolic mechanisms, synthetic consortia, and translational challenges

Cigar tobacco fermentation is a microbiome-dependent solid-state process in which deliberate microbial intervention can alter macromolecule degradation, aroma formation, undesirable chemical constituents, and mould risk. This critical review evaluates whether published interventions support a transition from empirical bioaugmentation to controllable microbial biotechnology. Literature identified through Web of Science and ScienceDirect, principally covering 2010-2026, is assessed by separating process proximity from measured function, causal mechanism, and scale of validation. Functional microbial inoculant is used instead of probiotic except when reporting source terminology. Controlled studies support hydrolytic bacterial inoculants, strain-specific yeast fermentation, nitrate-pathway intervention for tobacco-specific nitrosamine control, engineered carotenoid biotransformation, defined synthetic communities, and volatile-mediated suppression of postharvest cigar-leaf moulds. These findings do not establish universal superiority of mixed cultures, industrial repeatability, or application-specific biosafety. Many lactic-acid-bacterial antifungal and mycotoxin-control mechanisms remain supported mainly by non-tobacco matrices. The evidence framework therefore records representative sources, experimental context, mechanistic limitations, and missing validation separately. We propose measurable, application-dependent decision gates for strain identity, safety, matrix efficacy, metabolic stability, community compatibility, scale-up, and formulation. These gates are research and development proposals, not empirically validated industrial standards. Dominant bacterial guilds and complementary yeasts should be evaluated without conflating chemical-hazard reduction with the health risks of tobacco use.